Journal of Health Literacy

Journal of Health Literacy

Metabolic Factors as Mediators of the Association between Health Literacy and Incident Hypertension: Findings from the Shahrekord Persian Cohort Study

Document Type : Original Article

Authors
1 PhD, Department of Public Health, Social Determinants of Health Research Center, School of Health, Shahrekord University of Medical Sciences, Shahrekord, Iran.
2 PhD, Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-Communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran.
3 Professor, Department of Epidemiology and Biostatistics, School of Health, Shahrekord University of Medical Sciences, Shahrekord, Iran.
4 Assistant Professor, Department of Public Health, School of Health, Shahrekord University of Medical Sciences, Shahrekord, Iran.
5 Associate Professor, Social Determinants of Health Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran.
6 Assistant Professor, Department of Epidemiology and Biostatistics, School of Health, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Abstract
Background and Objective: Hypertension is a major global health concern, yet the role of health literacy in its development remains unclear, especially in Middle Eastern populations. This prospective cohort study examined the association between health literacy and incident hypertension in southwestern Iran.

Materials and Methods: This cohort study included 4,217 adults aged 35–70 years without baseline hypertension from the Shahrekord PERSIAN Cohort, followed for 7 years. Health literacy was assessed using the HELIA questionnaire, with inadequate literacy defined as below the 25th percentile. Incident hypertension was confirmed through physician diagnosis or antihypertensive medication use. Hierarchical logistic regression estimated odds ratios (ORs) with 95% confidence intervals (CIs), with progressive adjustment for confounders. Causal mediation analyses were conducted using Stata's mediate command.

Results: Participants' mean age was 47.55 ± 8.33 years. During follow-up, 107 incident hypertension cases (2.6%) were recorded. Mediation analyses showed significant indirect effects for triglycerides (27.4%, p = 0.001) and fasting blood sugar (15.6%, p = 0.027), though both fell below the 30% threshold for meaningful mediation, suggesting only partial mediation. These variables were therefore treated as confounders in the final model.
In the crude model, inadequate health literacy was linked to higher odds of hypertension (OR: 1.72, 95% CI: 1.02, 2.90). This association persisted after adjustment for age, ethnicity, BMI, physical activity, and depression (OR: 1.78, 95% CI: 1.02, 3.11). However, with further adjustment for fasting blood sugar and triglycerides, the association became non-significant (OR: 1.67, 95% CI: 0.95, 2.92). In the fully adjusted model, age, obesity, depression, and elevated triglycerides remained independently associated with hypertension.

Conclusion: Triglycerides and fasting blood sugar partially mediated the association between health literacy and incident hypertension. These findings suggest that metabolic factors may lie on the pathway between health literacy and hypertension, though the modest mediation proportions indicate that other pathways also contribute.
Keywords

Acknowledgements: The authors would like to thank the participants of the Shahrekord PERSIAN Cohort Study for their valuable contribution. We also acknowledge the staff of the PERSIAN cohort for their dedicated work in data collection and follow-up. We are grateful to the Shahrekord University of Medical Sciences for providing access to the cohort data.


Availability of data and materials: The data supporting the findings of this study are available from the Shahrekord PERSIAN Cohort Study but restrictions apply to the availability of these data, which were used under license for the current study. Data are available from the corresponding author upon reasonable request and with permission of the Shahrekord University of Medical Sciences.


Conflicts of interest: The authors declare that they have no competing interests.


Consent for publication: Not applicable. This manuscript does not contain any individual person's data in any form (including individual details, images, or videos).


Ethics approval and consent to participate: This study was conducted in accordance with the Declaration of Helsinki. The protocol of this study was approved by the Ethics Committee of Shahrekord University of Medical Sciences (approval number: IR.SKUMS.NUMHE.REC.1405.016). All participants provided written informed consent at the time of enrollment into the PERSIAN cohort study. For the present analysis, all data were anonymized before access.


Funding: This study received no specific funding from any funding agency in the public, commercial, or not-for-profit sectors. The Shahrekord PERSIAN Cohort Study was funded by the Ministry of Health and Medical Education of Iran and Shahrekord University of Medical Sciences.


Author Contributions: Vahid Khosravi: Conceptualization, Methodology, Writing – Original Draft, Supervision. Maede Hosseinnia: Investigation, Resources, Methodology, Writing – Review & Editing. Ali Ahmadi: Data curation, Methodology, Validation, Writing – Review & Editing. Masoumeh Alidosti: Investigation, Resources, Writing – Review & Editing. Elaheh Tavasooli:  Methodology, Visualization, Writing – Review & Editing. Samaneh Torkian: Conceptualization, Formal analysis, Methodology, Supervision, Writing – Review & Editing, Project administration. All authors read and approved the final manuscript.


AI Statement: During the preparation of this manuscript, the authors used DeepSeek AI (deepseek.com) for English language editing, literature search, and summarization. After using this tool, the authors reviewed and edited the content as necessary and take full responsibility for the content of the publication. No AI tools were used for data collection, statistical analysis, or drawing scientific conclusions.

 

Open Access Policy: This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/

1. Zhou B, Carrillo-Larco RM, Danaei G, Riley LM, Paciorek CJ, Stevens GA, et al. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. The lancet. 2021;398(10304):957-80.https://doi.org/10.1016/S0140-6736(21)01330-1 PMid:34450083
2. ZHANG Dongyan LY. Summary and interpretation of the World Health Organization "Global Report on Hypertension". Journal of Diagnostics Concepts & Practice. 2024;23(03):297-304.
3. Chowdhury SH, Hossain MA. Hypertension in Bangladesh: Race Against a Silent Killer. Journal of Medicine. 2026;27(1):1-2. https://doi.org/10.3329/jom.v27i1.88268
4. Geng T, Xu W, Gao H, Zhang J, Zou J, Wang K, et al. Relationship between control of cardiovascular risk factors and chronic kidney disease progression, cardiovascular disease events, and mortality in Chinese adults. Journal of the American College of Cardiology. 2024;84(14):1313-24. https://doi.org/10.1016/j.jacc.2024.06.041 PMid:39322325
5. WHO. First WHO report details devastating impact of hypertension and ways to stop it Sep 19, 2023 [cited 2026. Available from: https://epinews.emphnet.net/en/news/the-globe/the-world-health-organization-issues-the-first-report-detailing-the-devastating-impact-of-high-blood-pressure-and-ways-to-stop-it.
6. Heidari-Foroozan M, Rezaei N, Malekpour M-R, Behnoush AH, Ahmadi N, Abbasi-Kangevari M, et al. Hypertension prevalence and cascade of care in Iran: Updates from the STEPs 2021 national and subnational survey. Research Square. 2024. https://doi.org/10.21203/rs.3.rs-3842876/v1
7. Raeisi zadeh M, Cheraghian B, Hashemi SJ, Hosseini SA, Rahimi Z, Araban M, et al. Prevalence, Awareness, Treatment, Control, and Determinants of Hypertension: A Population-Based Cross-Sectional Study in Southwest Iran. Medical Journal of the Islamic Republic Of Iran. 2026;40(1):74-81. https://doi.org/10.47176/mjiri.40.11 PMid:42516625 PMCid:PMC13403879
8. Hajebi M, Farzi Y, Fe'li SN, Sharifi F, Rezaei N, Mirzad M, et al. Prehypertension and hypertension among older adults: prevalence, awareness, treatment, control and associated factors - findings from Iranian STEPS survey (2016 and 2021). Aging Clin Exp Res. 2026;38(1). https://doi.org/10.1007/s40520-026-03339-x PMid:41848931 PMCid:PMC13005809
9. Yang H, Jiang Y, Guo J, Wang J, Ma X, Chen K, et al. An atlas on multitudinous risk factors associated with incident hypertension: comprehensive exposome-wide association and wide-angled genetic analyses. European Journal of Preventive Cardiology. 2025;32(14):1347-60. https://doi.org/10.1093/eurjpc/zwae236 PMid:39024416
10. Basson J, Simino J, Rao D. Between candidate genes and whole genomes: time for alternative approaches in blood pressure genetics. Current hypertension reports. 2012;14(1):46-61. https://doi.org/10.1007/s11906-011-0241-8 PMid:22161147 PMCid:PMC7774509
11. Simões CF, Lopes LPN, Lara LDS, Cortês AL. Health literacy for elderly patients with high blood pressure: A scoping review. Res Social Adm Pharm. 2024;20(9):846-59. https://doi.org/10.1016/j.sapharm.2024.06.004 PMid:38890034
12. Beiranvandi A, Beiranvand A, Karami K, Mohammadi R. Association of health literacy, medication beliefs, and illness perception among older adults with hypertension: a community-based study. BMC Public Health. 2026;26(1). https://doi.org/10.1186/s12889-025-26123-4 PMid:41654774 PMCid:PMC12977793
13. Handayani N, Haryanto J, Sari D. Factors Influencing Blood Pressure Control in Older Adults Hypertension: A Systematic Review. Indonesian Journal of Global Health Research. 2025;7(1):939-46. https://doi.org/10.37287/ijghr.v7i1.5300
14. Horde GW, Huang E, Hammock J, Levitan EB, Zhu A, Hansen R, et al. Health Literacy and Hypertension: A Systematic Review. Circulation. 2023;148(Suppl_1):A17353-A. https://doi.org/10.1161/circ.148.suppl_1.17353
15. Loreto L, Linares-Jimenez F, de Zeeuw J, de Winter A. Health literacy and hypertension-related multimorbidity: unravelling the mediating role of self-management-insights from the lifelines cohort study. BMC Public Health. 2025;25(1):1530 https://doi.org/10.1186/s12889-025-22798-x PMid:40275236 PMCid:PMC12020009
16. Halladay JR, Donahue KE, Cené CW, Li Q, Cummings DM, Hinderliter AL, et al. The association of health literacy and blood pressure reduction in a cohort of patients with hypertension: The heart healthy lenoir trial. Patient education and counseling. 2017;100(3):542-9. https://doi.org/10.1016/j.pec.2016.10.015 PMid:27776790 PMCid:PMC5350034
17. Shi D, Li J, Wang Y, Wang S, Liu K, Shi R, et al. Association between health literacy and hypertension management in a Chinese community: a retrospective cohort study. Internal and Emergency Medicine. 2017;12(6):765-76. https://doi.org/10.1007/s11739-017-1651-7 PMid:28303441
18. Mohammadian Khonsari N, Shahrestanaki E, Ejtahed HS, Djalalinia S, Sheidaei A, Hakak-Zargar B, et al. Long-term Trends in Hypertension Prevalence, Awareness, Treatment, and Control Rate in the Middle East and North Africa: a Systematic Review and Meta-analysis of 178 Population-Based Studies. Curr Hypertens Rep. 2021;23(9):41 https://doi.org/10.1007/s11906-021-01159-0 PMid:34625888
19. Al-Hazmi AH, Alanazi ADM, Thirunavukkarasu A, Alriwely NS, Alrais MMF, Alruwaili ABS, et al. Evaluation of hypertension knowledge and its association with medication adherence among hypertensive patients attending primary health centers: a cross-sectional study from eastern Saudi Arabia. Front Public Health. 2024;12:1378561. https://doi.org/10.3389/fpubh.2024.1378561 PMid:39872100 PMCid:PMC11770004
20. Khosravi F, Jamali J. The Health Literacy Instruments for Adults (HELIA): Comparison of the Multiple Indicators Multiple Causes (MIMIC) Model and Multi-Group Confirmatory Factor Analysis (MG-CFA). Payesh (Health Monitor) Journal. 2025;24(3):379-87. https://doi.org/10.61186/payesh.24.3.379
21. Poustchi H, Eghtesad S, Kamangar F, Etemadi A, Keshtkar A-A, Hekmatdoost A, et al. Prospective epidemiological research studies in Iran (the PERSIAN Cohort Study): rationale, objectives, and design. American journal of epidemiology. 2018;187(4):647-55. https://doi.org/10.1093/aje/kwx314 PMid:29145581 PMCid:PMC6279089
22. Ahmadi A, Shirani M, Khaledifar A, Hashemzadeh M, Solati K, Kheiri S, et al. Non-communicable diseases in the southwest of Iran: profile and baseline data from the Shahrekord PERSIAN Cohort Study. BMC Public health. 2021;21(1):2275. https://doi.org/10.1186/s12889-021-12326-y PMid:34903205 PMCid:PMC8670056
23. Montazeri A, Tavousi M, Rakhshani F, Azin SA, Jahangiri K, Ebadi M, et al. Health Literacy for Iranian Adults (HELIA): development and psychometric properties. 2014.
24. Mahmoud Tavousi, AliasgharHaeri Mehrizi, shahram Rafiefar, Atoosa Solimanian, Fateme Sarbandi, Mona Ardestani, et al. Health literacy in Iran: findings from a national study. Payesh (Health Monitor) Journal. 2016;15(1):95-102.
25. Members WC, Blumenthal RS, Morris PB, Gaudino M, Johnson HM, Anderson TS, et al. 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of dyslipidemia: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2026;153(17):e1154-e276.
26. Care D. 2. Diagnosis and classification of diabetes: Standards of care in diabetes-2024. Diabetes Care. 2024;47(Suppl 1):S20-s42. https://doi.org/10.2337/dc24-S002 PMid:38078589
27. Symons M, Moore D. Hazard rate ratio and prospective epidemiological studies. Journal of clinical epidemiology. 2002;55(9):893-9. https://doi.org/10.1016/S0895-4356(02)00443-2 PMid:12393077
28. Hair JF, Black WC, Babin BJ, Anderson RE. Canonical correlation: A supplement to multivariate data analysis. Multivariate Data Analysis: A Global Perspective, 7th ed; Pearson Prentice Hall Publishing: Upper Saddle River, NJ, USA. 2010.
29. MacKinnon DP, Lockwood CM, Hoffman JM, West SG, Sheets V. A comparison of methods to test mediation and other intervening variable effects. Psychological methods. 2002;7(1):83. https://doi.org/10.1037/1082-989X.7.1.83 PMid:11928892 PMCid:PMC2819363
30. Preacher KJ, Kelley K. Effect size measures for mediation models: quantitative strategies for communicating indirect effects. Psychological methods. 2011;16(2):93. https://doi.org/10.1037/a0022658 PMid:21500915
31. Dezhkameh M, Moradinazar M, Najafi F. Clustering metabolic and behavioral risk factors for hypertension: evidence from a longitudinal cohort in western Iran. Scientific Reports. 2026. https://doi.org/10.1038/s41598-026-55844-8 PMid:42225909 PMCid:PMC13457851
32. Sadeghi M, Talaei M, Oveisgharan S, Rabiei K, Dianatkhah M, Bahonar A, et al. The cumulative incidence of conventional risk factors of cardiovascular disease and their population attributable risk in an Iranian population: The Isfahan Cohort Study. Advanced biomedical research. 2014;3:242. https://doi.org/10.4103/2277-9175.145749 PMid:25538928 PMCid:PMC4260292
33. Asgari S, Moazzeni SS, Azizi F, Abdi H, Khalili D, Hakemi MS, et al. Sex-specific incidence rates and risk factors for hypertension during 13 years of follow-up: the Tehran lipid and glucose study. Global heart. 2020;15(1):29-. https://doi.org/10.5334/gh.780 https://doi.org/10.5334/gh.847
34. Rezaianzadeh A, Johari MG, Baeradeh N, Seif M, Hosseini SV. Sex differences in hypertension incidence and risk factors: a population-based cohort study in Southern Iran. BMC Public Health. 2024;24(1):3575. https://doi.org/10.1186/s12889-024-21082-8 PMid:39716231 PMCid:PMC11668117
35. Babaei FN, Bijani A, Hosseini SR, Ghadimi R, Mouodi S. Predictors of 5-year Survival of Elderly with Hypertension. A Prospective Cohort Study. Journal of Research in Medical Sciences. 2024;29(1):36. https://doi.org/10.4103/jrms.jrms_859_22 PMid:39239083 PMCid:PMC11376721
36. Zhang Y, Zhu Y, He Y, Yan Y, Zhao Q, Du Y. Association of cumulative cholesterol-HDL-glucose index with blood pressure changes and risk of new-onset hypertension in middle-aged and older adults: a cohort study. Cardiovascular Diabetology. 2026. https://doi.org/10.1186/s12933-026-03081-8 PMid:41559691 PMCid:PMC12903659
37. Franklin SS. Hypertension in older people: part 1. J Clin Hypertens (Greenwich). 2006;8(6):444-9. https://doi.org/10.1111/j.1524-6175.2006.05113.x PMid:16760685 PMCid:PMC8109573
38. Faramarzi E, Ostadrahimi A, Nikniaz Z, Jafarabadi MA, Fakhari A, Somi M. Determination of the Best Anthropometric Index of Obesity for Prediction of Prehypertension and Hypertension in a Large Population - Based - Study; the Azar- Cohort. Iranian Red Crescent Medical Journal (IRCMJ). 2024;20(3):1-7. https://doi.org/10.5812/ircmj.59911
39. Jambarsang S, Soodejani MT, Tate R, Sefidkar R. How well do obesity indices predict undiagnosed hypertension in the Persian cohort (Shahedieh) adults community population of all ages? Health Science Reports. 2024;7(2):e1897. https://doi.org/10.1002/hsr2.1897 PMid:38405171 PMCid:PMC10885643
40. Yan J, Zhang M-z, He Q-q. Association of changes and cumulative measures of triglyceride-glucose index-body mass index with hypertension risk: a prospective cohort study. BMC Public Health. 2024;24(1):2652. https://doi.org/10.1186/s12889-024-20154-z PMid:39334211 PMCid:PMC11438062
41. Hall JE, do Carmo JM, da Silva AA, Wang Z, Hall ME. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Circulation research. 2015;116(6):991-1006. https://doi.org/10.1161/CIRCRESAHA.116.305697 PMid:25767285
42. Fang Z, Huang T, Zhang Q, Shi L, Huang R. The impact of depression on mortality among older adult patients with hypertension: a systematic review and meta-analysis. Frontiers in Public Health. 2025;13:1603785. https://doi.org/10.3389/fpubh.2025.1603785 PMid:40823226 PMCid:PMC12350467
43. Satapathy P, Gaidhane AM, Vadia N, Menon SV, Chennakesavulu K, Panigrahi R, et al. Association Between Depression and Risk of Hypertension: A Systematic Review and Meta‐Analysis. Brain and Behavior. 2025;15(9):e70931. https://doi.org/10.1002/brb3.70931 PMid:40999622
44. Hosseini SR, Amini N, Bijani A, Ghadimi R, Ahangari N, Faramarzi M. Trends in Depressive Symptoms and the Factors Affecting Them in Older Adults: A Prospective Cohort Study. Iranian Journal of Ageing. 2025;20(3):422-37. https://doi.org/10.32598/sija.2024.3919.1
45. Selejan O, Muresanu D. The 17th International Summer School of Neurology. International Summer School of Neurology; July 8-10, 2022; Hybrid Event.
46. Zhang X, Yang Y, Jiang Y-S. Triglyceride-Glucose Index as a Novel Biomarker for Major Adverse Cardiovascular Events. Angiology. 2025;76(6):602-3. https://doi.org/10.1177/00033197241231150 PMid:38296264
47. Welty FK, Alfaddagh A, Elajami TK. Targeting inflammation in metabolic syndrome. Translational research. 2016;167(1):257-80. https://doi.org/10.1016/j.trsl.2015.06.017 PMid:26207884 PMCid:PMC6800061
48. McNaughton CD, Kripalani S, Cawthon C, Mion LC, Wallston KA, Roumie CL. Association of health literacy with elevated blood pressure: a cohort study of hospitalized patients. Medical care. 2014;52(4):346-53. https://doi.org/10.1097/MLR.0000000000000101 PMid:24556896 PMCid:PMC4031281
49. Azarbad A, Aghnia T, Gharibzadeh A, Rafati S, Hashemi SM, Zarei H, et al. Cut-off points for anthropometric indices to screen for hypertension among Iranian adults of the Bandare-Kong cohort: a cross-sectional study. BMC Public Health. 2022;22(1):2064. https://doi.org/10.1186/s12889-022-14489-8 PMid:36369024 PMCid:PMC9652962

Articles in Press, Accepted Manuscript
Available Online from 03 October 2026